Results - Announcements
Viyash Scientific Ltd share price gained 0.65% to Rs 255.1 after the company's net profit inched up 6.76% to Rs 84.65 crore, while revenue from operations slightly gained 4.39% to Rs 987.94 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, easing 6.82%. It has marginally improved by 2.52% over last one week and ticked higher by 5.98% in last one month while the market capitalization of Viyash Scientific Ltd has increased 11.20% and 0.28% in the same period respectively.
Profit before tax (PBT) of Viyash Scientific Ltd stood at Rs 117.68 crore in Q2 FY27, climbing 14.96% year-on-year, and gaining 4.69% quarter-on-quarter. EBITDA came in at Rs 153 crore, declining 7.61% YoY and slipping 9.94% sequentially.
Total expenses grew marginally by 4.65% to Rs 868.33 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 438.51 crore, growing marginally by 8.99% YoY, while employee benefits expense was at Rs 184.83 crore, surging 13.64% YoY.
For FY26, revenue from operations grew 13.75% to Rs 3420.31 crore, while net profit soared by 1324.54% to Rs 224.65 crore, compared to previous FY. EBITDA jumped by 34797% to Rs 608.98 crore, and PBT surged 2548.10% to Rs 349.02 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 322.91 crore in FY26, as against Rs 344.8 crore in FY25.
Viyash Scientific Ltd jumped 11.52% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 3.42% during the same period.